SLC2A1 and acute myeloid leukemia: Moreover, previous studies showed the significant role of the PI3K/AKT/mTOR pathway in the regulation and expression of GLUT1, HK2, and PKM2, leading to the downregulation of glycolytic activity in AML cell lines (13).